DarioHealth Corp. (NASDAQ:DRIO) Sees Significant Growth in Short Interest

DarioHealth Corp. (NASDAQ:DRIO) was the target of a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 1,800,000 shares, a growth of 11.1% from the August 15th total of 1,620,000 shares. Based on an average daily trading volume, of 93,900 shares, the days-to-cover ratio is presently 19.2 days.

DarioHealth Stock Up 5.3 %

NASDAQ:DRIO traded up $0.05 during trading hours on Wednesday, hitting $0.92. 212,020 shares of the company traded hands, compared to its average volume of 119,331. The company has a quick ratio of 1.96, a current ratio of 2.26 and a debt-to-equity ratio of 0.34. The company has a market cap of $27.53 million, a PE ratio of -0.58 and a beta of 1.46. The firm’s 50-day simple moving average is $1.00 and its 200-day simple moving average is $1.28. DarioHealth has a one year low of $0.68 and a one year high of $3.49.

DarioHealth (NASDAQ:DRIO) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.08) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.51) by $0.43. DarioHealth had a negative net margin of 265.33% and a negative return on equity of 74.64%. The company had revenue of $6.26 million for the quarter, compared to analyst estimates of $7.57 million. Equities analysts predict that DarioHealth will post -1.21 earnings per share for the current year.

Hedge Funds Weigh In On DarioHealth

An institutional investor recently bought a new position in DarioHealth stock. Clarity Capital Partners LLC purchased a new stake in shares of DarioHealth Corp. (NASDAQ:DRIO) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 170,426 shares of the company’s stock, valued at approximately $293,000. Clarity Capital Partners LLC owned 0.63% of DarioHealth as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 33.39% of the company’s stock.

DarioHealth Company Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.